Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Breier

Showing results (181-190 of 269) with videos related to

Pageof 27
Sort By:
Psychopharmacology Series|January 1, 1987
Biochemical alterations produced by neuroleptics in man: studies of plasma homovanillic acid in schizophrenic patientsD Pickar, O M Wolkowitz, R Labarca, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 24, 2015
Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposureD Imrichova, L Messingerova, M Seres, et al.
Biological Psychiatry|November 15, 1992
Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humansA Breier, O Davis, R Buchanan, et al.
General Physiology and Biophysics|December 10, 2003
Hypoxia increases cell death in multidrug-resistant leukemia cells. Differences in viability and ultrastructure between sensitive and multidrug-resistant L1210 mouse leukemic cells under hypoxiaA H El-Saggan, I Dovinová, Z Sulová, et al.
The American Journal of Psychiatry|October 13, 1999
Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophreniaC M Adler, A K Malhotra, I Elman, et al.
The American Journal of Psychiatry|August 1, 1989
Alprazolam augmentation of neuroleptics in schizophreniaO M Wolkowitz, A Breier, A Doran, et al.
Archives of General Psychiatry|November 1, 1988
Early parental loss and development of adult psychopathologyA Breier, J R Kelsoe, P D Kirwin, et al.
Archives of General Psychiatry|July 1, 1988
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary resultsO M Wolkowitz, A Breier, A Doran, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1996
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteersA K Malhotra, D A Pinals, H Weingartner, et al.
The American Journal of Psychiatry|January 1, 1994
Effects of clozapine on positive and negative symptoms in outpatients with schizophreniaA Breier, R W Buchanan, B Kirkpatrick, et al.
Pageof 27

Showing results (181-190 of 269) with videos related to

Sort By:
Pageof 27
Psychopharmacology Series|January 1, 1987
Biochemical alterations produced by neuroleptics in man: studies of plasma homovanillic acid in schizophrenic patientsD Pickar, O M Wolkowitz, R Labarca, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 24, 2015
Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposureD Imrichova, L Messingerova, M Seres, et al.
Biological Psychiatry|November 15, 1992
Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humansA Breier, O Davis, R Buchanan, et al.
General Physiology and Biophysics|December 10, 2003
Hypoxia increases cell death in multidrug-resistant leukemia cells. Differences in viability and ultrastructure between sensitive and multidrug-resistant L1210 mouse leukemic cells under hypoxiaA H El-Saggan, I Dovinová, Z Sulová, et al.
The American Journal of Psychiatry|October 13, 1999
Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophreniaC M Adler, A K Malhotra, I Elman, et al.
The American Journal of Psychiatry|August 1, 1989
Alprazolam augmentation of neuroleptics in schizophreniaO M Wolkowitz, A Breier, A Doran, et al.
Archives of General Psychiatry|November 1, 1988
Early parental loss and development of adult psychopathologyA Breier, J R Kelsoe, P D Kirwin, et al.
Archives of General Psychiatry|July 1, 1988
Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary resultsO M Wolkowitz, A Breier, A Doran, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 1, 1996
NMDA receptor function and human cognition: the effects of ketamine in healthy volunteersA K Malhotra, D A Pinals, H Weingartner, et al.
The American Journal of Psychiatry|January 1, 1994
Effects of clozapine on positive and negative symptoms in outpatients with schizophreniaA Breier, R W Buchanan, B Kirkpatrick, et al.
Pageof 27